Plasminogen Activator Inhibitor-2 Polymorphism Associates with Recurrent Coronary Event Risk in Patients with High HDL and C-Reactive Protein Levels

• James P. Corsetti ,

  * E-mail: James_Corsetti@urmc.rochester.edu

  Affiliation Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America

  ⨯
• Peter Salzman,

  Affiliation Department of Biostatistics and Computational Biology, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America

  ⨯
• Dan Ryan,

  Affiliation Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America

  ⨯
• Arthur J. Moss,

  Affiliation Department of Medicine, Cardiology Unit, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America

  ⨯
• Wojciech Zareba,

  Affiliation Department of Medicine, Cardiology Unit, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America

  ⨯
• Charles E. Sparks

  Affiliation Department of Pathology and Laboratory Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, United States of America

  ⨯